ArticleCancers2021

Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders.

Luca Ielasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.